Jill O’Donnell-Tormey, Ph.D.

Jill O’Donnell-Tormey, Ph.D. has served as a member of our Board of Directors since May 2022. Dr. O’Donnell-Tormey is a senior advisor of the Cancer Research Institute (“CRI”), a nonprofit organization dedicated exclusively to advancing immunotherapy to treat, control and cure all cancers. She joined the organization in 1987 and served Chief Executive Officer and Director of Scientific Affairs from 1993 to August 2024. As a recognized leader and advocate for cancer immunotherapy, Dr. O’Donnell-Tormey has spearheaded programs at CRI designed to identify and advance promising combination immunotherapies as well as facilitate global coordination of clinical research initiatives across academia and industry. Dr. O’Donnell-Tormey serves on the boards of The City University of New York (“CUNY”), Richmond University Medical Center, and the Staten Island Foundation. Dr. O’Donnell-Tormey served as a research associate in the department of medicine at Cornell University Medical College and as a postdoctoral fellow in the laboratory of cellular physiology and immunology at The Rockefeller University. She holds a Doctor of Philosophy in cell biology from the SUNY Downstate Medical Center and earned a B.S. in chemistry from Fairleigh Dickinson University.